Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 4,226 | 4,281 | 3,624 |
| Operating Income | -4,226 | -4,281 | -3,624 |
| Other Income | 63 | 80 | 35 |
| Pre-tax Income | -4,163 | -4,201 | -3,589 |
| Net Income Continuous | -4,163 | -4,201 | -3,589 |
| Net Income | $-4,163 | $-4,201 | $-3,589 |
| EPS Basic Total Ops | -960.00 | -1,152.00 | -1,077.00 |
| EPS Basic Continuous Ops | -941.86 | -1,129.30 | -1,055.59 |
| EPS Diluted Total Ops | -960.00 | -1,152.00 | -1,077.00 |
| EPS Diluted Continuous Ops | -941.86 | -1,129.30 | -1,055.59 |
| EBITDA(a) | $-4,220 | $-4,275 | $-3,616 |